LIFE PHARMA-DETOX PROJECT
Demonstration of an innovative method for the detoxification of pharmaceutical wastewater from pharmaceutical facilities. This project aims to the development and implementation of an innovative, economically viable and cost-efficient system for the transformation of pharmaceutical compounds, present in wastewater, into non-toxic substances. In this way, the environmental impacts occurring due to poor controlled discharge of APIs in the wastewater sewage system will be eliminated.
Latest News
Tests to optimise operation of RO pilot plant continue by the NTUA and Medochemie researchers, at the LIFE Pharma Detox pilot unit in Cyprus. The operation of the RO unit has started and the results are very promising! The difference of turbidity between inlet and permeate stream is shown in the picture.
On-site Visit at MEDOCHEMIE in Limassol, Cyprus. 2nd Monitoring Visit at the premises of our coordinating partner MEDOCHEMIE in Limassol, Cyprus. A great opportunity to connect in person with all project beneficiaries and discuss key progress updates. Grateful for the warm welcome from our hosts and the valuable insights shared -driving the project forward together.
Urban wastewater is one of the main sources of water pollution if it is not collected and treated according to EU rules. It is often contaminated with bacteria, viruses, harmful chemicals, including micropollutants, and an overload of nutrients, which, when untreated and discharged into the environment, affect our health and damage our rivers, lakes, and...
LIFE PHARMA-DETOX
The project is co-funded by LIFE
The project is co-funded by LIFE, the EU’s financial instrument supporting environmental, nature conservation and climate action projects throughout the EU.
Our Project is also part of the LIFE projects that are co-Funded by the Green Fund. The project team would like to thank the Green Fund for co-funding the NTUA activities. More specifically, according to the Decision Number 242.4/2022 of the Management Board of the Green Fund, the amount of 60,000 Euro was approved for the year 2022.